
Factor Replacement Therapy Schematic
This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking,
Year: 2007
Language: English
Author(s): World Federation of Hemophilia
Format: Document
A summary of discussions held at the World Federation of Hemophilia’s Global Forum on the Safety and Supply of Hemophilia Treatment Products, which brings together patient groups, healthcare providers, regulators, industry representatives, and not-for-profit fractionators.

This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking,

In the Tuesday morning medical plenary, Erik Berntorp describes his vision of hemophilia treatment and medical advances in 2030.

This eLearning module presents Section 4 of the WFH Guidelines for the Management of Hemophilia: Hemostatic Agents. Detailed illustrations, interactive

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may

Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese This is not an official WFH translation. This resource has been